| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
15002134094 |
| Email: |
marketing@targetmol.cn |
| Products Intro: |
Product Name:THR-β agonist 1
CAS:2648403-17-0
Package:100mg/RMB 17500;25mg/RMB 10600;50mg/RMB 13800
|
| Company Name: |
Biorbyt Ltd.
|
| Tel: |
+44 (0)1223 859 353 |
| Email: |
info@biorbyt.com |
| Products Intro: |
Product Name:THR-β agonist 1
CAS:2648403-17-0
|
1,2,4-Triazine-3,5(2H,4H)-dione, 2-[3,5-dichloro-4-[[1,6-dihydro-5-(1-methylethyl)-6-oxo-3-pyridazinyl]oxy]phenyl]-6-(fluoromethyl)- manufacturers
- THR-β agonist 1
-
- $2500.00 / 100mg
-
2025-10-27
- CAS:2648403-17-0
- Min. Order:
- Purity:
- Supply Ability: 10g
|
| | 1,2,4-Triazine-3,5(2H,4H)-dione, 2-[3,5-dichloro-4-[[1,6-dihydro-5-(1-methylethyl)-6-oxo-3-pyridazinyl]oxy]phenyl]-6-(fluoromethyl)- Basic information |
| Product Name: | 1,2,4-Triazine-3,5(2H,4H)-dione, 2-[3,5-dichloro-4-[[1,6-dihydro-5-(1-methylethyl)-6-oxo-3-pyridazinyl]oxy]phenyl]-6-(fluoromethyl)- | | Synonyms: | 1,2,4-Triazine-3,5(2H,4H)-dione, 2-[3,5-dichloro-4-[[1,6-dihydro-5-(1-methylethyl)-6-oxo-3-pyridazinyl]oxy]phenyl]-6-(fluoromethyl)-;THR-β agonist 1 | | CAS: | 2648403-17-0 | | MF: | C17H14Cl2FN5O4 | | MW: | 442.23 | | EINECS: | | | Product Categories: | | | Mol File: | 2648403-17-0.mol | ![1,2,4-Triazine-3,5(2H,4H)-dione, 2-[3,5-dichloro-4-[[1,6-dihydro-5-(1-methylethyl)-6-oxo-3-pyridazinyl]oxy]phenyl]-6-(fluoromethyl)- Structure](CAS/20210305/GIF/2648403-17-0.gif) |
| | 1,2,4-Triazine-3,5(2H,4H)-dione, 2-[3,5-dichloro-4-[[1,6-dihydro-5-(1-methylethyl)-6-oxo-3-pyridazinyl]oxy]phenyl]-6-(fluoromethyl)- Chemical Properties |
| density | 1?+-.0.1 g/cm3(Predicted) | | pka | 5.33±0.40(Predicted) | | form | Solid | | color | White to off-white |
| | 1,2,4-Triazine-3,5(2H,4H)-dione, 2-[3,5-dichloro-4-[[1,6-dihydro-5-(1-methylethyl)-6-oxo-3-pyridazinyl]oxy]phenyl]-6-(fluoromethyl)- Usage And Synthesis |
| Uses | THR-β Agonist 1 is a potent and selective agonist of THRβ. Thyroid hormone receptor mediates the physiological activity of thyroid hormones which plays a key role in normal growth and development of the body and in maintaining metabolic balance. THR-β Agonist 1 has the potential for the research of thyroid hormone receptor-related diseases (extracted from patent WO2021104288A1, compound 2)[1]. | | References | [1] Hejun lv, et al. 1,2,4-triazine-3,5-dione compound and its preparation method and application. Patent WO2021104288A1. |
| | 1,2,4-Triazine-3,5(2H,4H)-dione, 2-[3,5-dichloro-4-[[1,6-dihydro-5-(1-methylethyl)-6-oxo-3-pyridazinyl]oxy]phenyl]-6-(fluoromethyl)- Preparation Products And Raw materials |
|